ESG Data

Profile

Overview

https://www.kyowakirin.com/overview/index.html

Financial Data

Financial Data
Financial Data
  • *1:
    Revenue, Overseas revenue, R&D expenses and Core Operating Profit on and after 2018 represent figures in the continued operation (Pharmaceuticals) excluding the discontinued operation (Bio-chemicals).
  • *2:
    Dividend payout ratio for 2021 is the ratio of dividends to core earnings (Profit attributable to owners of parent – Other income and expenses (excluding tax effects)).

Major Trade Associations

You can see this table by scrolling horizontally.

Name of Association
Japan Business Federation
FPMAJ (The Federation of Pharmaceutical Manufacturers’ Associations of JAPAN)
JPMA (Japan Pharmaceutical Manufacturers Association)
PMAT (The Pharmaceutical Manufactureres' Association of Tokyo)

Participation in Initiatives

You can see this table by scrolling horizontally.

Initiative name
Figures in parentheses indicate the years signed/supported
Our involvement
The UN Global Compact (2005)* We will comply with the 10 principles set forth in the areas of "human rights," "labor," "environment," and "anti-corruption" by the United Nations Global Compact. We also participate on the Environmental Management Subcommittee, the Anti-Corruption Subcommittee, and the Reporting Research Subcommittee of the Global Compact Network Japan, which is a local network.
RE100 (2020)* Kirin Holdings aims to achieve 100% renewable energy electric power consumption by 2040. The Group's climate change measures are consistent with those of Kirin Holdings, and the Group will continue to expand renewable energy use to achieve its goals.
  • *
    The Kirin Group is the signatory and member.

Environment

Environmental Management

You can see this table by scrolling horizontally.

Policy
Environment Kirin Group Environmental Vision 2050Open in new window
Kyowa Kirin Group Environmental Policy
Climate Change The Kirin Group Environmental Vision 2050 sets out a social vision of a society that has overcome climate change.
Kirin Group Environmental Vision 2050Open in new window
The Kyowa Kirin Group Environmental Policy calls for striving to save resources and energy, and reduce greenhouse gas emissions to prevent global warming.
Kyowa Kirin Group Environmental Policy
Water Resources The Kirin Group Environmental Vision 2050 sets out a social vision of a society that uses sustainable water resources.
Kirin Group Environmental Vision 2050Open in new window
The Kyowa Kirin Group Environmental Policy calls for water consumption to be reduced and waste reduced and recycled.
Kyowa Kirin Group Environmental Policy

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018 2019 2020
ISO14001 certified sites*2 Sites In Japan 4 4 4
Sites Outside Japan 0 0 0
Sites Global 4 4 4
Ratio of ISO14001 certified sites % Global 80 80 80
Number of environmental law violations*3 Case Global 0 0 0
Fines paid due to environmental law violations Yen Global 0 0 0
  • *1:
    In Japan, the production and research sites of Kyowa Kirin Co., Ltd. are covered. Overseas, Kyowa Kirin China Pharmaceutical Co., Ltd. is covered (small-scale production and research facilities are excluded).
  • *2:
    As of May 2018, we have completed the update of the ISO 14001 to the latest standard ISO 14001:2015 on all sites, and January 1 2019, we shifted from the third party certification to the self-declaration.
  • *3:
    The number of violations includes those related to water quality and volume (permits, standards, regulations, etc.).

Environmental Targets

You can see this table by scrolling horizontally.

2020 targets
Category Target Boundary*1 Base Year/
Results in Base Year
Target Year/
Results in Target Year
Achievement
Status
Climate Change CO2 Emissions (SCOPE1,2):
15% Reduction from 1990 Level
Global Year 1990/
447,256 t-CO2
Year 2020/
278,107 t-CO2
(Reduced by 37.8%)
CO2 Emissions (SCOPE1,2):
15% Reduction from 2005 Level
In Japan Year 2005/
269,945 t-CO2
Year 2020/
133,233 t-CO2
(Reduced by 50.6%)
Air Pollutants Volatile Organic Compound (VOC) Emissions:
50% Reduction from 2003 Level
In Japan Year 2003/
935 t
Year 2020/
242 t
(Reduced by 74.1%)
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd., Kyowa Iryo Kaihatsu Co., Ltd., Kyowa Hakko Bio Co., Ltd. and Kyowa Pharma Chemical Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd., Kyowa Kirin, Inc., BioKyowa Inc., Shanghai Kyowa Amino Acid Co., Ltd. and THAI KYOWA BIOTECHNOLOGIES CO., LTD. are covered.

You can see this table by scrolling horizontally.

2030 targets
Category Target Boundary*1 Base Year/Results in Base Year
Climate Change CO2 Emissions in 2030 (SCOPE1,2):
55% Reduction from 2019 Level
Global Year 2019/51,931 t-CO2
Water Resources Water Use in 2030:
40% Reduction from 2019 Level
Global Year 2019/2,229 1000m3
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered.

CO2 SCOPE1, 2

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018*2 2019*2,3 2020*2
Emissions
(SCOPE1+2)
t-CO2 In Japan 51,409 49,273 38,095
t-CO2 Outside Japan 1,912 2,658 2,979
t-CO2 Global 53,321 51,931 41,074
Emissions Year-on-Year
(SCOPE1+2)
% In Japan -16.6 -4.2 -22.7
% Outside Japan -10.3 39.0 12.1
% Global -16.4 -2.6 -20.9
Unit CO2 Emissions t-CO2/
100 Million Yen-
Sales Revenue
Global 19.6 17.2 12.9
Emissions
(SCOPE1)
t-CO2 In Japan 17,657 16,849 16,728
t-CO2 Outside Japan 56 396 456
t-CO2 Global 17,713 17,244 17,185
Emissions
(SCOPE2)
t-CO2 In Japan 33,752 32,425 21,366
t-CO2 Outside Japan 1,856 2,262 2,522
t-CO2 Global 35,608 34,687 23,889
Emissions (on Each Site)
*Data of Major Sites in Japan are Listed below as "Site Data."
t-CO2 Kyowa Iryo Kaihatsu Co., Ltd. 843 983
t-CO2 Kyowa Kirin China Pharmaceutical Co., Ltd. 1,912 2,018 2,261
t-CO2 Kyowa Kirin, Inc.
(Research Division (La Jolla, CA))
640 717
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.
  • *2:
    Each CO2 emission factors: ①Fuel CO2 emission factors: "Greenhouse Gas Emissions Calculation and Reporting Manual (Ministry of the Environment of Japan/Ministry of Economy, Trade and Industry of Japan)" factors. ②Electricity CO2 emission factors: Emission factors published by individual power companies (If none published, Emission factors by country from IEA’s CO2 Emissions from Fuel Combustion for the year in question).
  • *3:
    The base year value was also recalculated by the same method by changing the calculation method and scope in accordance with the SBT Guidance.

CO2 SCOPE3

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1,2 2018 2019 2020 Calculation Method*3
Category1:
Purchased goods and services
t-CO2 In Japan 1,148 60,454 62,287 Calculated by multiplying the amount of materials and resources purchased by the emission factors at the time each was manufactured.
GHG emissions from contract manufacturing have included in the calculation scope since 2019.
t-CO2 Outside Japan 28 1,040 108
t-CO2 Global 1,176 61,494 62,395
Category2:
Capital goods
t-CO2 In Japan 27,555 39,497 Calculated by multiplying the amount of capital investment by the emission factor
t-CO2 Outside Japan 336 662
t-CO2 Global 27,891 40,159
Category 3:
Fuel and energy related activities not included in Scope 1 or 2
t-CO2 In Japan 5,862 6,038 5,083 Calculated by multiplying the amount of fuel and electricity purchased by the emission factor of each energy type
t-CO2 Outside Japan 182 304 352
t-CO2 Global 6,044 6,343 5,435
Category 4:
Transportation and delivery
(upstream)
t-CO2 In Japan 218 236 201 Calculated by multiplying the product shipment volume and the volume of materials and resources purchased by the transport distance and then multiplying by the emission factor for each transportation method
t-CO2 Outside Japan 3 40 7
t-CO2 Global 221 276 209
Category 5:
Waste generated in operations
t-CO2 In Japan 1,760 777 1,348 Calculated by multiplying the amount of waste generated, etc. by the emission factors for each waste treatment method
t-CO2 Outside Japan 3 63 60
t-CO2 Global 1,763 840 1,408
Category 6:
Business travel
t-CO2 In Japan 861 479 Calculated by multiplying the number of employees by the average annual travel distance for each travel method and then multiplying by the emission factor for each travel method.
The calculations for 2020 take into account the ratio of business trip restrictions imposed to prevent the spread of COVID-19 infections.
Category 7:
Employee commutin
t-CO2 In Japan 2,446 1,059 Calculated by multiplying the number of employees by the average annual travel distance for each travel method and multiplying by the emission factor for each travel method.
The calculations for 2020 take into account the ratio of attendance restrictions to prevent the spread of COVID-19 infections.
Category 8:
Leased assets (upstream)
t-CO2 In Japan 2,402 1,584 Calculated by multiplying the fuel consumption of leased business vehicles by the emission factor
Category 9:
Transportation and distribution (downstream)
Not calculated
Category 10:
Processing of sold products
Not calculated
Category 11:
Use of sold products
Excluded because there is no energy use based on product use due to the nature of pharmaceutical products
Category 12:
End-of-life treatment of sold products
Being considered for calculation
Category 13:
Leased assets (downstream)
t-CO2 Global 2,059 2,402 Calculated by multiplying the amount of energy used by the leased assets by the emission factor of each energy type
Category 14:
Franchises
Not calculated because no franchise stores are being operated
Category 15:
Investments
Not calculated because we are not a business providing financial services
  • *1:
    In 2018, the plants and research laboratories of Kyowa Kirin Co., Ltd. are covered. Overseas, Kyowa Kirin China Pharmaceutical Co., Ltd. is covered.
  • *2:
    Since 2019, in Japan, Kyowa Kirin Co., Ltd., Kyowa Media Service Co., Ltd., Kyowa Iryo Kaihatsu Co., Ltd., Kyowa Kirin Frontier Co., Ltd. and Kyowa Kirin plus Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered.
  • *3:
    The emission intensities, etc., listed in the Ministry of the Environment's "Emissions Database ver.3.1 for Calculation of Organizations' Greenhouse Gas Emissions, etc., Through Their Supply Chains" are used here.

Energy

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018*2 2019*2 2020*2
Energy Consumption GJ Global 1,023,053 1,023,310 1,037,816
Energy Consumption
Year-on-Year
% Global -15.7 0.0 1.4
Unit Energy Consumption GJ/
100 Million Yen-
Sales Revenue
Global 377 335 326
Electric Power Purchased
(Renewable Electricity)
1,000kWh Global 0 0 23,432
Electric Power Purchased
(Non Renewable Electricity)
1,000kWh Global 68,800 70,878 48,986
City Gas 1,000Nm3 Global 6,377 5,988 5,900
Natural Gas
(Excluding LNG)
1,000Nm3 Global 153 181
Heavy Oil A kL Global 0.02 84 90
Kerosene kL Global 1,336 1,272 1,297
Light Oil kL Global 0.019 2.88 3.11
Steam GJ Global 17,495 7,197 8,397
Photovoltaic Power Generation 1,000kWh In Japan 132 135 131
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.
  • *2:
    Energy conversion factor: "the Act on the Rational Use of Energy" factors.

Water Resources

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018 2019 2020
Water Withdrawal
Total Amount
1,000m3 In Japan 2,303 2,215 1,730
1,000m3 Outside Japan 6 14 16
1,000m3 Global 2,309 2,229 1,746
Water Withdrawal
Municipal Potable Water
1,000m3 Global 268 281 272
Water Withdrawal
Surface Water from Rivers, Lakes and Natural Ponds
1,000m3 Global 1273 1,155 1,146
Water Withdrawal
Groundwater from Wells and Boreholes
1,000m3 Global 762 793 328
Water Withdrawal
Used Quarry Water Collected in the Quarry
1,000m3 Global 0 0 0
Water Withdrawal
External Wastewater
1,000m3 Global 0 0 0
Water Withdrawal
Harvested Rainwater
1,000m3 Global 0 0 0
Water Withdrawal
Sea Water, Water Extracted from the Sea or the Ocean
1,000m3 Global 0 0 0
Total Water Withdrawal in Water Stress Areas*2 1,000m3 Global 84 100 82
Ratio of Water Withdrawal in Water Stress Areas % Global 3.7 4.5 4.7
Units of Water Used 1,000m3/
100 Million Yen-
Sales Revenue
Global 0.85 0.73 0.55
Amount of Circulated Water Usage 1,000m3 Global 5,787 3,790 3,735
Ratio of Circulated Water Usage % Global 251 170 214
Water Discharge
Total Amount
1,000m3 In Japan 1,902 2,001 1,838
1,000m3 Outside Japan 6 7 8
1,000m3 Global 1,908 2,009 1,846
Water Discharge
Release into Sea
1,000m3 Global 0 0 0
Water Discharge
Release into Rivers
1,000m3 Global 1,822 1,889 1,735
Water Discharge
Sewage Water
1,000m3 Global 103 119 110
Water Pollution
COD
t In Japan 2.3 2.3 2.6
t Outside Japan 0.0 0.0 0.0
t Global 2.3 2.3 2.6
Water Pollution
Total Nitrogen
t In Japan 4.0 4.0 5.3
t Outside Japan 0.0 0.0 0.0
t Global 4.0 4.0 5.3
Water Pollution
Total Phosphorus
t In Japan 0.3 0.5 0.6
t Outside Japan 0.0 0.0 0.0
t Global 0.3 0.5 0.6
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.
  • *2:
    The amount of water intake by Kyowa Kirin Co., Ltd.'s Ube Plant and Kyowa Kirin China Pharmaceutical Co., Ltd., which have high water stress assessments in water risk assessments using water risk assessment tools (WRI Aqueduct and WWF Water Risk Filter) as well as online surveys and questionnaire surveys.

Material, Containers and Packaging

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018 2019 2020
Raw Material Consumption t In Japan 182 166 122
t Outside Japan 9 6
t Global 182 175 128
Containers and Packaging Consumption t In Japan 181 544 423
t Outside Japan 35 41 80
t Global 216 585 503
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.

Waste

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018 2019 2020
Waste Generated t In Japan 1,409 1,160 1,408
t Outside Japan 6 16 8
t Global 1,415 1,176 1,416
External Recycled Waste t In Japan 1,397 1,142 591
t Outside Japan 0 0 0
t Global 1,397 1,142 591
Final Disposal t In Japan 1.5 1.1 0.0
t Outside Japan 0.01 4.9 2.7
t Global 1.5 6.0 2.7
Final Disposal Rate % In Japan 0.11 0.09 0.004
% Outside Japan 0.20 31 32
% Global 0.11 0.51 0.19
Basel Convention Hazardous Wastes Global None None None
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.

Air Pollutants

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018 2019 2020
SOx t In Japan 0 0.3 0.3
t Outside Japan 0 0 0
t Global 0 0.3 0.3
Unit SOx Emissions t/
100 Billion Yen-
Sales Revenue
Global 0 0.1 0.1
NOx t In Japan 7.4 6.2 5.5
t Outside Japan 0 0 0
t Global 7.4 6.2 5.5
Unit NOx Emissions t/
100 Billion Yen-
Sales Revenue
Global 2.7 2.0 1.7
Dust t In Japan 0.05 0.09 0.09
t Outside Japan 0 0 0
t Global 0.05 0.09 0.09
Unit Dust Emissions t/
100 Billion Yen-
Sales Revenue
Global 0.02 0.03 0.03
VOC t In Japan 0.14 0.05 0.07
Unit VOC Emissions t/
100 billion Yen-
Sales revenue
Global 0.05 0.01 0.02
ODS Emissions t In Japan 0.167 0.005 0.003
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.

PRTR Discharge

You can see this table by scrolling horizontally.

Indicator Unit Boundary*1 2018 2019 2020
Released into Air t In Japan 0.02 0.02 0.03*2
Units Released into Air t/
100 Billion Yen-
Sales Revenue
In Japan 0.01 0.01 0.01
Released into Water t In Japan 0 0 0*2
Units Released into Water t/
100 Billion Yen-
Sales Revenue
In Japan 0 0 0
Released into Soil t In Japan 0 0 0*2
Units Released into Soil t/
100 Billion Yen-
Sales Revenue
In Japan 0 0 0
  • *1:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd. and Kyowa Iryo Kaihatsu Co., Ltd. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. since 2019.
  • *2:
    In 2020, the breakdown of emissions of PRTR substances is as follows.

You can see this table by scrolling horizontally.

Number Designated by Ordinance Name of Substance Atmosphere (ton) Water Area (ton) Soil (ton)
13 Acetonitrile 0.020 0.000 0.000
127 Chloroform 0.004 0.000 0.000
232 N,N-Dimethylformamide 0.003 0.000 0.000
179 Dioxins (mg-TEQ) 0.00 0.00 0.00

Site Data

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Unit Energy Consumption GJ/m2-Floor Kyowa Kirin
Tokyo Research Park
2.71 2.56 2.48
CO2 Emissions*1 t 3,023 2,751 2,602
Water Withdrawal 1,000m3 19 18 15
Water Discharge 1,000m3 17 16 13
COD t 0
Total Nitrogen t 0.06 0.05 0.04
Total Phosphorus t 0.00 0.00 0.01
Waste Generated t 79.0 58.3 51.3
Final Disposal t 0.0 0.0 0.0
SOx t 0 0 0
NOx t 0.20 0.21 0.21
Dust t 0 0 0
Unit Energy Consumption GJ/m2-Floor Fuji Site 5.02 4.69 4.66
CO2 Emissions*1 t 16,489 14,978 14,151
Water Withdrawal 1,000m3 1,890 1,785 1,328
Water Discharge 1,000m3 1,566 1,621 1,479
COD t 1.46 1.12 1.16
Total Nitrogen t 1.36 1.58 1.07
Total Phosphorus t 0.08 0.20 0.07
Waste Generated t 237 162 203
Final Disposal t 0.0 0.9 2.0
SOx t 0 0 0
NOx t 2.80 1.77 1.24
Dust t 0 0 0
Unit Energy Consumption GJ/m2-Floor Kyowa Kirin
Takasaki Plant
8.33 7.18 7.45
CO2 Emissions*1 t 22,659 21,646 11,667
Water Withdrawal 1,000m3 315 314 308
Water Discharge 1,000m3 315 314 308
COD t 0.62 0.54 0.45
Total Nitrogen t 2.62 2.37 4.01
Total Phosphorus t 0.26 0.30 0.48
Waste Generated t 806 521 748
Final Disposal t 0.8 0.8 0.8
SOx t 0 0 0
NOx t 2.69 2.63 2.56
Dust t 0.05 0.05 0.05
Unit Energy Consumption GJ/m2-Floor Kyowa Kirin
Ube Plant
6.86 6.61 6.69
CO2 Emissions*1 t 9,239 9,056 8,691
Water Withdrawal 1,000m3 78.0 91.9 73.2
Water Discharge 1,000m3 4.26 43.8 31.8
COD t 0.23 0.63 0.95
Total Nitrogen t 0.00 1.62 0.14
Total Phosphorus t 0.00 0.95 0.01
Waste Generated t 287 300 462
Final Disposal t 0.7 0.7 1.0
SOx t 0 0 0
NOx t 1.70 1.51 1.42
Dust t 0 0 0
  • *1:
    Emission factors for CO2 emissions: the emission factors listed in the "Greenhouse Gas Emission Calculation and Reporting Manual" (Ministry of the Environment of Japan/Ministry of Economy or Japan, Trade and Industry) are used for fuel, while the emission factors made public by individual electric power companies are used for electricity. Energy conversion factor: "the Act on the Rational Use of Energy" factors. The base year (2019) value was also recalculated using the same method by changing the calculation method and scope in accordance with the SBT Guidance.

Social

Employment

You can see this table by scrolling horizontally.

Policy
Talent Management Kyowa Kirin Group Talent Management Policy
Freedom of Association and Collective Bargaining The Kirin Group Human Rights Policy clearly advocates for freedom of association and respect for the right to collective bargaining.
The Kirin Group's human rights policy(P2)PDF file

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Number of Employees Persons Consolidated 7,242 5,267 5,423
Number of Employees Persons In Japan 5,269 3,792 3,909
Number of Employees Persons In North America 424 300 348
Number of Employees Persons In EMEA 678 716 658
Number of Employees Persons In Asia/Oceania 871 459 508
Number of Employees Persons Non-
consolidated
3,918 3,619 3,736
Number of Male Employees Persons Non-
consolidated
2,768 2,519 2,570
Number of Female Employees Persons Non-
consolidated
1,150 1,100 1,166
Ratio of Female Employees % Non-
consolidated
29.4 30.4 31.2
Average Years of Service Years Non-
consolidated
18.4 17.7 17.5
Average Years of Service of Male Years Non-
consolidated
18.8 18.0 17.7
Average Years of Service of Female Years Non-
consolidated
17.4 17.1 16.9
Average Age Age Non-
consolidated
42.8 42.4 42.6
Average Age of Male Age Non-
consolidated
43.7 43.4 43.2
Average Age of Female Age Non-
consolidated
40.7 40.7 41.2
Percentage of Employees by Age Group
(Under 30)
% Non-
consolidated
11.7 12.1 11.4
Percentage of Employees by Age Group
(30-49)
% Non-
consolidated
62.5 63.6 63.0
Percentage of Employees by Age Group
(50 and over)
% Non-
consolidated
25.9 24.3 25.6
Average Annual Salary Yen Non-
consolidated
8,562,688 8,610,603 8,778,251
Number of New Hires Persons Non-
consolidated
89 146 246
Number of New Hires of Male Persons Non-
consolidated
54 92 153
Number of New Hires of Female Persons Non-
consolidated
35 54 93
Ratio of Female in New Hires % Non-
consolidated
39 37 38
Ratio of Mid-Career Hires % Non-
consolidated
36 61 66
Number of Full-time Staff Turnover Persons Non-
consolidated
177 460 152
Full-time Staff Turnover Rate*1 % Non-
consolidated
4.5 12.7 4.1
Full-time Employee Voluntary Turnover Rate % Non-
consolidated
2.4 2.1 2.1
Number of Temporary Employees Persons Non-
consolidated
90 89 105
Ratio of Temporary Employees % Non-
consolidated
2.2 2.4 2.7
Rate of Participation in a Labor Union % Non-
consolidated
100 100 100
  • *1:
    The number of employees who left the organization during this reporting period / the total number of full-time employees at the end of the reporting period (including employees who leave the organization voluntarily or due to dismissal, retirement, or death in service).

Training

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Total Hours Spent on Employee Development Training*1 Hours Non-consolidated 18,925
Average Hours Spent on Employee Development Training per Employee*1 Hours Non-consolidated 5.1
  • *1:
    The results cover training conducted by the Human Resources Department.

Work-life Balance

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Number of Employees who took Childcare Leave Persons Non-consolidated 44 51 72
Number of Male Employees who took Childcare Leave Persons Non-consolidated 3 9 27
Number of Female Employees who took Childcare Leave Persons Non-consolidated 41 42 45
Number of Employees Using Systems Reducing Working Hours for Childcare Persons Non-consolidated 79 81 80
Number of Male Employees Using Systems Reducing Working Hours for Childcare Persons Non-consolidated 0 0 2
Number of Female Employees Using Systems Reducing Working Hours for Childcare Persons Non-consolidated 79 81 78
Number of Employees Using the Nursing Care Leave System
(Children or Family)
Persons Non-consolidated 56 386 465

Diversity

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Number of Managers Persons Non-consolidated 1,129 1,064 1,095
Number of Male Managers Persons Non-consolidated 1,028 961 972
Number of Female Managers Persons Non-consolidated 101 103 123
Ratio of Female Managers % Non-consolidated 8.9 9.7 11.2
Number of Disabled Employees*1 Persons Consolidated
(In Japan)
143 115 104
Ratio of Disabled Employees*1 % Consolidated
(In Japan)
2.45 2.59 2.45
  • *1:
    As of June each year. The figures are for the Kyowa Kirin Group (domestic).

Human Rights

You can see this table by scrolling horizontally.

Policy
Human Rights Kirin Group's Human Rights PolicyPDF file
Prohibition of Discrimination The Kirin Group Human Rights Policy explicitly prohibits all forms of discrimination, including that based on race, ethnicity, nationality, social status, family origin, gender, ability or disability, health condition, thought/belief, sexual orientation/gender identity, and differences in occupation and form of employment.
The Kirin Group's human rights policy(P2)PDF file

Occupational Health and Safety

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Average Number of Actual Hours Worked per Year for each Employee Hours Non-consolidated 1,818.4 1,829.8 1,859.6
Number of Accidents that Required Time off from Work Cases *1 2 1 0
Number of Work-related Employee Fatalities Persons Consolidated (In Japan) 0 0 0
Number of Work-related Contractor Fatalities Persons Consolidated (In Japan) 0 0 0
Accident Frequency Rate % *1 0.36 0.13 0.00
Accident Severity Rate % *1 0.011 0.0062 0
Ratio of Employees Undergoing Regular Health Checkups % Non-consolidated 99.9 99.9 99.9
Annual Leave Used Rate % Non-consolidated 72 78 75
Ratio of Employees who Smoke % Non-consolidated 12.7 12.2 4.4
  • *1:
    The plants and research laboratories in Japan of Kyowa Kirin, Kyowa Medex (excluded in 2018 due to deconsolidation), Kyowa Hakko Bio and Kyowa Pharma Chemical are covered until 2018. In 2019, all locations of Kyowa Kirin are covered

Community

You can see this table by scrolling horizontally.

Policy
Community Kyowa Kirin Group Community Involvement Activities Policy

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Amount of Community Investments*1 Millions of Yen Non-consolidated 764 704 635
  • *1:
    Excludes temporary investments including support for disaster-stricken areas.Since 2016, we have contributed to the Global Health Innovative Technology Fund (GHIT Fund), a public-private partnership to promote the creation of new drugs for infectious diseases in developing countries.

Procurement

You can see this table by scrolling horizontally.

Policy
Procurement Kyowa Kirin Group Procurement Policy
Kyowa Kirin CSR Procurement GuidebookPDF file

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Number of Responses to CSR Questionnaire Company *1 440 707 684
  • *1:
    We conducted questionnaire surveys of suppliers in Japan through 2018. Since 2019, we have extended the scope of these questionnaire surveys to overseas suppliers as well.

Governance

Corporate Governance

You can see this table by scrolling horizontally.

Policy
Corporate Governance Corporate Governance PolicyPDF file
Corporate Governance ReportPDF file

You can see this table by scrolling horizontally.

Indicator*1
Organization Type Company with Audit & Supervisory Board
Number of Directors Eight (Masashi Miyamoto, Yutaka Osawa, Toshifumi Mikayama, Akira Morita, Yuko Haga, Jun Arai, Takashi Oyamada, Noriya Yokota)
Term of Office of Directors in Articles of Incorporation One Year
Chairperson of the Board Akira Morita (Independent Outside Director)
Career Summary of the Board of Directors Notice of Convocation of the 98th Ordinary General Meeting (P6-17)PDF file
Average Age of Directors Age 63.2
Number of Independent Outside Directors Four(Akira Morita, Yuko Haga, Jun Arai, Takashi Oyamada)
Number of Female Directors One
Number of Board Meetings 14 times
Attendance Rate at Meetings of the Board of Directors 98% (Director), 100% (Audit & Supervisory Board Members)
Please see "Attendance at Board of Directors, Audit & Supervisory Board, and Nomination and Nomination & Remuneration Consultative Committee" for officer-specific data on participation.
Evaluation of Effectiveness of the Board Effectiveness evaluations are conducted every year. Please see below for the results of the 2020 effectiveness evaluations.
Annual Report 2020 (P41)PDF file
Number of Audit & Supervisory Board Members Five (Hiroshi Komatsu, Masaki Ueno, Yuji Inoue, Keiji Kuwata, Tomomi Yatsu)
Term of Office of Audit & Supervisory Board Members in Articles of Incorporation Four Years
Career Summary of Audit & Supervisory Board Members Annual Report 2020 (P47)PDF file
Number of Outside Audit & Supervisory Board Members Three (Masaki Ueno, Yuji Inoue, Tomomi Yatsu). Of these, Yuji Inoue and Tomomi Yatsu are independent outside auditors.
Number of Female Audit & Supervisory Board Members One
Attendance Rate at Meetings of the Audit & Supervisory Board 100%
Please see "Attendance at Board of Directors, Audit & Supervisory Board, and Nomination & Remuneration Consultative Committee Meetings" for officer-specific data on participation.
Number of Members of the Nomination & Remuneration Consultative Committee Nine (Masashi Miyamoto, Yutaka Osawa, Toshifumi Mikayama, Akira Morita, Yuko Haga, Jun Arai, Takashi Oyamada, Yuji Inoue, Tomomi Yatsu)
Chairperson of the Nomination & Remuneration Consultative Committee Jun Arai (Independent Outside Director)
Number of Independent Outside Officers Six
Attendance Rate at Meetings of the Nomination & Remuneration Consultative Committee 98%
Please see "Attendance at Board of Directors, Audit & Supervisory Board, and Nomination & Remuneration Consultative Committee" for officer-specific data on participation.
Professional Skills of Officers Annual Report 2020 (P40)PDF file
Number of Female Executive Officers One
Remuneration of Officers Annual Report 2020 (P42)PDF file
Claw-back Provision Yes(Executive Directors and Executive Officers)
Introduction of Anti-takeover Measures None
  • *1:
    Data is current as of the end of March 2021. However, the numbers of Board of Directors, Audit & Supervisory Board, and Nomination & Remuneration Consultative Committee and attendance rates reflect the meetings/rates from January 1 to December 31, 2020.

You can see this table by scrolling horizontally.

Attendance at Board of Directors, Audit & Supervisory Board, and Nomination & Remuneration Consultative Committee (2020)
Name Position Attendance at Board of Directors Attendance at Audit & Supervisory Board Attendance at Nomination & Remuneration Consultative Committee
Masashi Miyamoto Representative Director President and
Chief Executive Officer
100%
(14/14 times)
- 100%
(15/15 times)
Yutaka Osawa Representative Director
Executive Vice President
100%
(14/14 times)
- 100%
(15/15 times)
Toshifumi Mikayama Director of the Board
Executive Vice President
100%
(14/14 times)
- -
Akira Morita Director of the Board
(Independent Outside Director)
100%
(14/14 times)
- 100%
(15/15 times)
Yuko Haga Director of the Board
(Independent Outside Director)
100%
(14/14 times)
- 100%
(15/15 times)
Jun Arai*2 Director of the Board
(Independent Outside Director)
100%
(14/14 times)
100%
(13/13 times)
100%
(15/15 times)
Takashi Oyamada*3 Director of the Board
(Independent Outside Director)
- - -
Noriya Yokota Director of the Board 100%
(14/14 times)
- -
Hiroshi Komatsu Full-time Audit &
Supervisory Board Member
100%
(14/14 times)
100%
(13/13 times)
-
Masaki Ueno*4 Full-time Audit &
Supervisory Board Member
(Outside)
100%
(10/10 times)
100%
(10/10 times)
-
Yuji Inoue*5 Audit & Supervisory
Board Member
(Independent Outside)
100%
(14/14 times)
100%
(13/13 times)
100%
(11/11 times)
Keiji Kuwata Audit & Supervisory
Board Member
100%
(14/14 times)
100%
(13/13 times)
-
Tomomi Yatsu*3 Audit & Supervisory
Board Member
(Independent Outside)
- - -
  • *2:
    Jun Arai served as an auditor prior to being appointed as a director on March 24, 2021, so his track record for 2020 is that of an auditor
  • *3:
    Takashi Oyamada and Tomomi Yatsu were first appointed executives on March 24, 2021, so they have no track record for 2020.
  • *4:
    Masaki Ueno was appointed an Audit & Supervisory Board member on March 19, 2020, so his post-appointment track record is shown.
  • *5:
    Yuji Inoue has served as a member of the Nomination and Remuneration Advisory Committee since March 2020, and his track record since this time is shown.

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Board of Directors
Number of Directors Persons Non-consolidated 7 8 7
Number of Independent Outside Directors Persons Non-consolidated 2 3 3
Number of Female Directors Persons Non-consolidated 1 1 1
Ratio of Independent Outside Directors Non-consolidated 28.5 37.5 42.8
Ratio of Female Directors Non-consolidated 14.2 12.5 14.2
Number of Meetings Times Non-consolidated 15 13 14
Attendance Rate
(Director)
Non-consolidated 98 98 98
Attendance Rate
(Audit & Supervisory Board Members)
Non-consolidated 97 100 100
Audit & Supervisory Board
Number of Audit & Supervisory Board Members Persons Non-consolidated 5 5 5
Number of Outside Audit & Supervisory Board Members Persons Non-consolidated 3 3 3
Number of Female Audit & Supervisory Board Members Persons Non-consolidated 0 0 0
Ratio of Outside Audit & Supervisory Board Members Non-consolidated 60 60 60
Ratio of Female Audit & Supervisory Board Members Non-consolidated 0 0 0
Number of Meetings Times Non-consolidated 14 14 13
Attendance Rate Non-consolidated 97 100 100
Nomination & Remuneration Consultative Committee*1
Number of Members of the Nomination & Remuneration Consultative Committee Persons Non-consolidated - 7 7
Number of Independent Outside Officers Persons Non-consolidated - 4 5
Ratio of Independent Outside Officers Non-consolidated - 57.1 71.4
Number of Meetings Times Non-consolidated - 14 15
Attendance Rate Non-consolidated - 100 98
Remuneration of Officers
Total Remuneration of Directors (Excluding Outside Directors)*2 Millions of Yen Non-consolidated 373(6) 394(5) 262(4)
Total Remuneration of Outside Directors*2 Millions of Yen Non-consolidated 27(3) 38(4) 46(3)
Total Remuneration of Company Auditors
(Excluding Outside Company Auditors)*2
Millions of Yen Non-consolidated 26(2) 26(3) 27(1)
Total Remuneration of Outside Company Auditors*2 Millions of Yen Non-consolidated 51(4) 51(3) 56(4)
Remuneration of CEO Millions of Yen Non-consolidated - 127 115
  • *1:
    The Nomination and Remuneration Advisory Committee was established in 2019 by integrating the Nomination Advisory Committee and the Remuneration Advisory Committee. The pre-integration track records of these committees are not shown.
  • *2:
    The number in parentheses indicates the number of persons involved.

Remuneration for Accounting Auditors

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Remuneration for Independent Auditors Millions of Yen Non-consolidated 110 104 88
Audit Fees Millions of Yen Non-consolidated 100 85 84
Non-Audit Fees Millions of Yen Non-consolidated 10 19 5
Remuneration for Those who Belong to the Same Network as Independent Auditors (excluding the above) Millions of Yen Non-consolidated+Subsidiaries 108 73 125
Audit Fees Millions of Yen Subsidiaries 57 68 112
Non-Audit Fees Millions of Yen Non-consolidated+Subsidiaries 51 5 12

Business Ethics

You can see this table by scrolling horizontally.

Policy
Code of Conduct Kyowa Kirin Group Code of ConductPDF file
Political Contributions The Kyowa Kirin Group prohibits illegal political contributions.
Kyowa Kirin Group Code of Conduct(P4)PDF file

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Number of Participants in Compliance Training*1 Persons Consolidated
(In Japan)
5,994 4,411 4,633
Number of Employees Receiving Code of Conduct Training*1 Persons Consolidated
(In Japan)
- - 4,638
Number of Employees Receiving Whistleblower System Training*1 Persons Consolidated
(In Japan)
- - 4,683
Number of Employees Receiving Personal Information Protection Training*1 Persons Consolidated
(In Japan)
- - 4,584
Number of Reports through the Compliance Line Cases Consolidated 20 27 29
Political Contributions Millions of Yen Non-consolidated 6 6 6
  • *1:
    Participants include temporary and contract employees, etc.

Anti-Corruption

You can see this table by scrolling horizontally.

Policy
Anti-Bribery and Anti-Corruption Kyowa Kirin Group Code of ConductPDF file
Kyowa Kirin Group Policy for Anti-Bribery Measures
Kyowa Kirin CSR Procurement GuidebookPDF file

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Number of Employees Receiving Anti-bribery and Corruption Training Persons Consolidated - - 6,154
Number of Employees Facing Disciplinary Dismissals Due to the Violation of Anti-bribery or Corruption Laws Cases Consolidated - - 0
Fines, Penalties, or Settlements Imposed for the Violation of Anti-bribery or Corruption Laws Yen Consolidated - - 0

Tax

You can see this table by scrolling horizontally.

Policy
Tax Kyowa Kirin Group Tax Policy

You can see this table by scrolling horizontally.

Indicator Unit Boundary 2018 2019 2020
Income Taxes Paid 100 Millions of Yen Consolidated 89 227 287
Income Taxes Paid 100 Millions of Yen In Japan 61 203 229
Income Taxes Paid 100 Millions of Yen Outside Japan 28 24 58